Cardinal Health, Inc. $CAH Stock Holdings Lowered by Banque Cantonale Vaudoise

Banque Cantonale Vaudoise trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 31.3% in the first quarter, HoldingsChannel reports. The institutional investor owned 12,970 shares of the company’s stock after selling 5,911 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Cardinal Health were worth $2,741,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. Nordea Investment Management AB boosted its stake in shares of Cardinal Health by 328.3% during the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after acquiring an additional 494,731 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Cardinal Health by 44.9% during the third quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after purchasing an additional 707,495 shares during the period. Procyon Advisors LLC raised its position in shares of Cardinal Health by 78.7% during the fourth quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock worth $3,499,000 after purchasing an additional 7,499 shares during the period. Sierra Summit Advisors LLC purchased a new stake in shares of Cardinal Health during the third quarter valued at $9,897,000. Finally, Banco Santander S.A. lifted its holdings in shares of Cardinal Health by 12.7% during the third quarter. Banco Santander S.A. now owns 117,354 shares of the company’s stock valued at $18,420,000 after purchasing an additional 13,228 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.7%

Shares of CAH stock opened at $234.70 on Friday. The company has a market capitalization of $54.97 billion, a price-to-earnings ratio of 35.89, a P/E/G ratio of 1.27 and a beta of 0.52. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $237.79. The stock’s fifty day simple moving average is $205.54 and its 200-day simple moving average is $210.11.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same period last year, the company posted $2.35 EPS. The business’s quarterly revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is 31.19%.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of analyst reports. Wells Fargo & Company dropped their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Evercore reduced their price objective on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Wall Street Zen cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Monday, June 15th. Leerink Partners reissued an “outperform” rating and issued a $275.00 target price on shares of Cardinal Health in a research report on Monday, March 9th. Finally, Citigroup cut their price target on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus target price of $246.93.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.